Cargando…
Mycobacterium smegmatis, a Promising Vaccine Vector for Preventing TB and Other Diseases: Vaccinomics Insights and Applications
Mycobacterium smegmatis (M.sm) is frequently used as an alternative model organism in Mycobacterium tuberculosis (M.tb) studies. While containing high sequence homology with M.tb, it is considered non-pathogenic in humans. As such it has been used to study M.tb and other infections in vivo and more...
Autores principales: | Xie, Weile, Wang, Longlong, Luo, Dan, Soni, Vijay, Rosenn, Eric H., Wang, Zhe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459588/ https://www.ncbi.nlm.nih.gov/pubmed/37631870 http://dx.doi.org/10.3390/vaccines11081302 |
Ejemplares similares
-
Rv2629 Overexpression Delays Mycobacterium smegmatis and Mycobacteria tuberculosis Entry into Log-Phase and Increases Pathogenicity of Mycobacterium smegmatis in Mice
por: Liu, Dan, et al.
Publicado: (2017) -
Quantum vaccinomics platforms to advance in vaccinology
por: de la Fuente, José, et al.
Publicado: (2023) -
Transcriptome Landscape of Mycobacterium smegmatis
por: Li, Xinfeng, et al.
Publicado: (2017) -
Population heterogeneity in Mycobacterium smegmatis and Mycobacterium abscessus
por: Born, Sarah E. M., et al.
Publicado: (2023) -
Immunoinformatics and reverse vaccinomic approaches for effective design
por: Parihar, Arpana, et al.
Publicado: (2022)